ALFA Finder| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 126.2 | 126.4 | 107.1 |
| Other income | 2.0 | 1.6 | 1.6 |
| Total income | 128.2 | 128.0 | 108.7 |
| Profit before exceptional items & tax | 17.2 | 15.9 | 11.1 |
| Profit before tax | 17.2 | 15.9 | 11.1 |
| Net profit | 12.7 | 14.6 | 7.7 |
| Operating margin | 13.4% | 12.4% | 10.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +64.90% |
|---|---|
| Net profit, quarter on quarter | -13.00% |
| Revenue, year on year | +17.80% |
| Operating profit, year on year | +75.40% |
| Operating profit, quarter on quarter | -17.70% |
BSE results filing, NSE: GPTHEALTH. Figures extracted from the filing.
GPT Healthcare Ltd: key numbers
- Share price
- ₹145.02
- Market cap
- ₹1,190 Cr
- Revenue (annual)
- ₹472.6 Cr
- Net profit (annual)
- ₹42.22 Cr
- P/E (TTM)
- 22.9×Sector 54.5×
- Promoter holding
- 65.57%+0.00% QoQ
- FII holding
- 3.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GPT Healthcare Ltd
All →GPT Healthcare Earnings Call Transcript: Key Takeaways
Q2 revenue rose 14.1% to ₹135.6 Cr and EBITDA 23.9%, driven by occupancy and volume. Raipur break-even slipped from Q3 FY27 to Q1 FY28 amid ~₹9 Cr Q2 losses. Management gave no new quantified targets beyond FY27 growth.
GPT Healthcare Results Update
GPT Healthcare filed a press release on unaudited Q2 and H1 FY27 results, reporting H1 total income of Rs 266.8 Cr and PAT of Rs 28.1 Cr. The release carries a P&L highlights table without the full SEBI results statement.
GPT Healthcare Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹135.6 Cr (+14.0%), EBITDA ₹29.8 Cr (21.5% margin), PAT ₹15.4 Cr (+45.2%). H1 PAT ₹28.1 Cr (+53.9%). Eastern India expansion; 1,000-bed target.
GPT Healthcare Dividend
GPT Healthcare's board declared an interim dividend of ₹1.00 per share for FY2026-27. Record date is November 12, 2026, with payment expected by December 4, 2026.
GPT Healthcare Q2 FY27 Results: Net Profit ₹15.4 Cr, Up 45.3% YoY
GPT Healthcare approved unaudited Q2 and half-year results, with H1 revenue of Rs 26,182.60 lakh. A 10% interim dividend was declared with a November 12 record date.
- Key figure
- Net profit ₹15.4 Cr · +45.3% YoY
GPT Healthcare Board Meeting Date
GPT Healthcare will hold a board meeting on 05 Nov 2026 to consider Q2 and half-year unaudited results and a possible interim dividend for FY 2026-27. Trading window stays closed until 07 Nov 2026.